Designing CAR Tregs for Neurodegenerative Disease Therapy

Time: 11:30 am
day: Day 2 Treg Cell Therapy Track AM

Details:

  • Targeting disease sites in the CNS
  • Utilizing disease modifying molecules to improve therapeuticactivity
  • Harnessing CARs to improve Treg persistence in the CNS

Speakers: